INVA Q1 2017 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$40M+67.5% YoY

Gross Profit

$40M99.1% margin

Operating Income

$29M72.5% margin

Net Income

$17M41.6% margin

EPS (Diluted)

$0.15

QoQ Revenue Growth

-7.2%

Cash Flow

Operating Cash Flow

$28M

Free Cash Flow

$28M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$392M

Total Liabilities

$726M

Stockholders' Equity

-$334M

Cash & Equivalents

$160M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$40M	$24M	+67.5%
Gross Profit	$40M	$24M	+68.8%
Operating Income	$29M	$18M	+67.4%
Net Income	$17M	$4M	+279.8%